← Eichor
Study identifier: NCT04678167 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

Condition: Vestibular Neuritis  ·  Sponsor: University Hospital, Brest

PhaseNA
Planned participants51
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.

This description comes directly from the study's public registry record.

Talk to the study team

Jean-Christophe LECLERE, Dr  ·  02.98.22.33.78  ·  jean-christophe.leclere@chu-brest.fr

Always discuss trial participation with your own doctor first.

Locations (2)

CHU de BrestBrest, FranceRecruiting
CH Pays de MorlaixMorlaix, FranceTerminated

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04678167